Related Experiment Video
Updated: May 28, 2026

05:31
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
First-in-Human Orthotopic Transcatheter Tricuspid Valve Replacement in a Patient With a Left Ventricular Assist
Connor P Craig1, Payton D Kendsersky1, Nicolas H Pope2
1Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
JACC. Case Reports
|May 27, 2026
Summary
Transcatheter tricuspid valve replacement (TTVR) offers a feasible solution for patients with severe tricuspid regurgitation (TR) post-left ventricular assist device (LVAD) implantation. This novel approach improved symptoms and reduced inotropic support needs.
Area of Science:
- Cardiology
- Interventional Cardiology
- Heart Failure Management
Background:
- Severe tricuspid regurgitation (TR) is a frequent complication following left ventricular assist device (LVAD) implantation.
- TR post-LVAD is linked to increased mortality, with surgical interventions showing inconsistent benefits.

